ncRNA name
BANCR
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
miR-203/CSE1L
Cancer name
Colorectal Cancer
Cancer site
Colon, Rectum, and Anus
Treatment type
Chemotherapy
Drug
Adriamycin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
32
Male patients
19
Female patients
13
Age range and number
18(<=60)+14(>60)
PMID
Description
BANCR knockdown suppressed CRC progression and strengthened chemosensitization of CRC cells to ADR possibly by regulating miR-203/CSE1L.
Tissue resource
colorectal cancer tumor tissues and adjacent normal tissues
human colorectal cancer cell lines HCT116
None
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Liaoning Cancer Hospital
China Center for Type Culture Collection
Country
China
Continent
Asia